Optimizing safety surveillance for COVID-19 vaccines

被引：35

作者：

Chandler, Rebecca E. ^{[1
]}

机构：

[1] Uppsala Monitoring Ctr, Uppsala, Sweden

来源：

NATURE REVIEWS IMMUNOLOGY | 2020年 / 20卷 / 08期

关键词：

D O I：

10.1038/s41577-020-0372-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to propel vaccine safety monitoring into the twenty-first century.

引用

页码：451 / 452

页数：2

共 10 条

[1]

European Medicines Agency, 2020, COVID-19: How EMA fast-tracks development support and approval of medicines and vaccines

[2] COVID-19 vaccine design: the Janus face of immune enhancement [J].

Hotez, Peter J. ;

Corry, David B. ;

Bottazzi, Maria Elena .

NATURE REVIEWS IMMUNOLOGY, 2020, 20 (06) :347-348

[3] Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines [J].

Izurieta, Hector S. ;

Zuber, Patrick ;

Bonhoeffer, Jan ;

Chen, Robert T. ;

Sankohg, Osman ;

Laserson, Kayla F. ;

Sturkenboom, Miriam ;

Loucq, Christian ;

Weibel, Daniel ;

Dodd, Caitlin ;

Black, Steve .

VACCINE, 2013, 31 (35) :3623-3627

[4] Adversomics: The Emerging Field of Vaccine Adverse Event Immunogenetics [J].

Poland, Gregmy A. ;

Ovsyannikova, Inna G. ;

Jacobson, Robert M. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (05) :431-432

[5] The COVID-19 vaccine development landscape [J].

Thanh Le, Tung ;

Andreadakis, Zacharias ;

Kumar, Arun ;

Gomez Roman, Raul ;

Tollefsen, Stig ;

Saville, Melanie ;

Mayhew, Stephen .

NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (05) :305-306

[6]

*VACC CONF PROJ, 2018, STAT VACC CONF EU 20

[7]

World Health Organization, 2012, GLOB VACC SAF BLUEPR

[8]

World Health Organization, 2019, GLOB VACC SAF BLUEPR

[9]

World Health Organization, 2017, ANN 9 GUID CLIN EV V

[10]

World Health Organization (WHO) , 2020, 10 THREATS GLOB HLTH

← 1 →